Hudson Bay Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Hudson Bay Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-35,000	Closed	-$1.16M	–	696
2020 Q2	$1.16M	Buy	+35,000	New	+$1.11M	0.02%	368
2020 Q1	–	Sell	-30,000	Closed	-$592K	–	640
2019 Q4	$592K	Sell	30,000 -49,493	-62%	-$791K	0.01%	339
2019 Q3	$1.03M	Sell	79,493 -3,007	-4%	-$36.3K	0.03%	313
2019 Q2	$1.03M	Buy	+82,500	New	+$1.1M	0.02%	328
2014 Q4	–	Sell	-100,000	Closed	-$1.13M	–	241
2014 Q3	$1.13M	Hold	100,000	–	–	0.03%	161
2014 Q2	$1.21M	Buy	+100,000	New	+$1.18M	0.04%	143

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Hudson Bay Capital Management's MNTA Position: Q3 2020 in Review

Hudson Bay Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 35,000 shares — an estimated $1.16M sold.

Hudson Bay Capital Management first reported a position in MNTA in Q2 2014 and held it in 6 quarters. The position peaked at $1.21M in Q2 2014. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Hudson Bay Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Hudson Bay Capital Management sold 35,000 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.16M.
Hudson Bay Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 6 quarters.
Hudson Bay Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.21M in Q2 2014.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Hudson Bay Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.